A Study of Tor Kinase Inhibitor in Advanced Tumors
Clinical trial NCT00731263 · COMPLETED
Trial details
- NCT number
- NCT00731263
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2010-11-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.